PubMed Health⌕ Search

Biomedical subjects

S Sakamoto

Publications and source records attributed to S Sakamoto.

At least 1,063 records · Page 59Linked to original sources

Effects of lycopene on spontaneous mammary tumour development in SHN virgin mice.

Effects of the chronic ingestion of lycopene, a carotenoid from tomato, on the development of spontaneous mammary tumours were examined in a high mammary tumour strain of SHN virgin mice. Beginning at 40 days of age, the control and the experimental groups were allowed free access to an AIN-76TM diet and a diet supplemented further with lycopene at the concentration of 5.0 x 10(-5)%, respectively. The treatment significantly suppressed the mammary tumour development, which suppression was associated with the decrease in the mammary gland activity of thymidylate synthetase, and serum levels of free fatty acid and prolactin. Body weight was little affected and no deleterious side-effects of lycopene were detected. All results show that lycopene could be promising as a chemopreventive agent for mammary and other types of tumours.

Animals↗

Clinicopathological stages and pyrimidine nucleotide synthesis in human mammary carcinomas.

The object of this study was to evaluate activities of thymidylate synthetase (TS) and thymidine kinase (TK) in relation to histopathological features of human mammary carcinomas, as well as clinical classification of patients. The TS and TK are key enzymes on the de novo and salvage pathways, respectively, for pyrimidine nucleotide synthesis. High TS and TK activities have been found in rapidly proliferating tissues. Clinical stage and TNM post-surgical histopathological classification of 20 patients with mammary carcinomas, during the period of 1988-1991, and TS and TK activities in each carcinoma were determined. Elevated TS and TK activities in mammary carcinomas corresponded to progressively worse clinical stages. Papillotubular carcinomas showed lower enzyme activity than that of solid-tubular and scirrhous types. TS activities continued to rise as the malignant invasion became more severe. The clinical prognosis of patients with mammary carcinomas appears to depend on the de novo synthesis of DNA in carcinomas.

Adult↗

Synergistic effect of oral UFT in combination with cisplatin on DNA synthesis in rat hepatocarcinomas.

We investigated the synergistic efficacy of CDDP and UFT, an oral anticancer derivative of 5-fluorouracil, on DNA synthesis of 3'-MeDAB-induced hepatocarcinomas in rats. Chronic treatment with CDDP slightly reduced tissue activities of thymidylate synthetase and thymidine kinase in the hepatocarcinomas, and, moreover, simultaneous administration of a low dose of UFT with CDDP markedly suppressed both enzyme activities, i.e., UFT and CDDP showed a potent synergism on DNA synthesis in hepatocarcinomas.

Administration, Oral↗

Protection by coffee cherry against spontaneous mammary tumour development in mice.

Chronic ingestion of an extract of coffee cherry (CC), the residue left after removal of coffee beans, induced a marked suppression of spontaneous mammary tumour development in a high mammary tumour strain of SHN virgin mice. The growth of normal and preneoplastic mammary glands was also apparently inhibited by the treatment. While the treatment resulted to some extent in a decrease of water intake and a retardation of body growth, the excretion of urinary components such as urea, allantoin and creatinine was increased and serum free fatty acid level was decreased by CC. Little modulation of the endocrine system was noted by the treatment. Finally, a promising chemopreventive role of CC in tumours is indicated.

Allantoin↗

Effects of danazol on proliferation and viability of 7,12-dimethylbenz(a)anthracene-induced mammary tumours in rats.

The suppressive effects of danazol, an isoxazol derivative of a synthetic steroid 17 alpha-ethinyltestosterone, on cellular viability and DNA synthesis in 7,12-dimethylbenz(a)anthracene induced mammary tumours were investigated in adult female rats by enzyme assays and immunohistochemistry with bromodeoxyuridine (BrdU). Rats treated with danazol for 30 days showed a decrease of plasma levels of luteinizing hormone and estradiol associated with a dysfunction in hypothalamo-hypophysial-gonadal axis, resulting in lower activities in succinate dehydrogenase and thymidine kinase, and a reduction of BrdU-immunoreactive cells in mammary tumours compared with the control, i.e., decreases of viability and pyrimidine nucleotide synthesis in tumour cells in danazol-treated rats.

9,10-Dimethyl-1,2-benzanthracene↗

Effects of danazol on thrombopoiesis in rats.

A synthetic analog of ethinyltestosterone, Danazol, has been used clinically for the treatment of immune thrombocytopenia. We investigated the effects of Danazol on thrombopoiesis in normal rats. Though 4-week treatment by Danazol slightly enhanced the DNA synthesizing enzyme activities and the number of S-phase cells in bone marrow and spleen, the number of megakaryocytes and thrombocytes were not increased in bone marrow and peripheral blood, respectively. These findings suggest that Danazol treatment will not induce thrombosis with thrombocytosis in normal human beings and animals.

Animals↗

Normal and neoplastic mammary gland growth in MMTV/TGF alpha transgenic mice.

Biochemical and Dynamic change of mammary glands in different reproductive states were studied in comparison with histological structures in female and male transgenic mice bearing human transforming growth factor alpha (TGF alpha) cDNA under the control of the mouse mammary tumour virus enhancer/promoter. Female and male F1 mice between SHN female and transgenic male mice were divided into TGF alpha (+) and TGF alpha (-) groups according to the presence of TGF alpha gene at approximately 50 days of age. While there was little difference in mammary gland contents of DNA and RNA in females at 2 months of age, both nucleic acid contents were elevated markedly in TGF alpha (+) female mice with large variations at 4 months. These extremely high DNA and RNA contents in the TGF alpha (+) group declined to the level of the TGF alpha (-) group in the middle of pregnancy and at the end of pregnancy, respectively. Thymidine kinase (TK) activity in the mammary glands as an index of DNA synthesis was significantly higher in TGF alpha (+) mice than in TGF alpha (-) mice at both 2 and 4 months of age and the high TK in TGF alpha (+) mice also declined to the level of TGF alpha (-) mice with pregnancy.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗

Regulation of pyrimidine nucleotide synthesis in rat hematopoiesis.

In an attempt to define a regulation of pyrimidine nucleotide synthesis in hematopoietic cells, we investigated the activities of thymidylate synthetase and thymidine kinase, and the cell cycle by flow cytometric DNA analysis and bromodeoxyuridine-immunohistochemistry during the recovery phase of hematopoietic cells in bone marrow after the hypoplastic period induced by cyclophosphamide treatment in rats. The hematopoietic cells first entered into cell cycle via the de novo pathway in pyrimidine nucleotide synthesis, and were secondly proliferated and differentiated via the salvage pathway. S-phase cells associated with a myeloid hematopoiesis increased earlier than those associated with an erythroid hematopoiesis in the recovery phase of in rat bone marrow.

Animals↗

Effects of 5-fluorouracil derivatives on papillomas induced by application of 7,12-dimethylbenz(a)anthracene in mice.

We examined the effects of an application of 5-fluorouracil (5-FU) ointment and a chronic oral administration of 1-(2-tetrahydrofuryl)-5-FU plus uracil (UFT) on 7,12-dimethyl-benz(a)-anthracene-induced squamous cell papillomas in mice. Although application of 5-FU ointment reduced the growth of papillomas slightly, chronic oral administration of UFT could prevent tumorigenesis and suppress the growth of papillomas, resulting in the reduction of the tumorous viability and DNA synthesis.

9,10-Dimethyl-1,2-benzanthracene↗

Oestrogen and progesterone receptors in mammary tumours of male SHN mice grafted with pituitaries in comparison with females.

Mammary tumour induced by pituitary grafting in SHN male mice is promising as an animal model for male breast cancer. In this study, these mice (group MC) were found to differ little from the intact female SHN (group FC) in cytosolic oestrogen receptor (OR) level in either normal or neoplastic mammary glands. On the other hand, Progesterone receptor (PR) level in normal glands tended to be lower in group MC than in group FC, which was recovered by chronic treatment with oestradiol benzoate (group OB). Little difference in PR level in mammary tumours was seen between groups MC and FC. Mammary tumorigenesis was significantly inhibited by chronic treatment with dihydrotestosterone to male mice with pituitary grafts (group DHT). This is associated with the significant decline in PR level in normal mammary glands, while not in mammary tumours. There were no significant correlations between OR and PR levels in normal or neoplastic mammary glands, or between normal and neoplastic mammary glands in OR or PR in all groups except group MC, in which the correlation between OR and PR in mammary tumour was significant. All findings indicate that OR and PR states in mammary tumours of male mice induced by pituitary grafting are essentially similar to the spontaneous mammary tumours of females as postulated in the human.

Animals↗

Chronological observation in early radiation myelopathy of the cervical spinal cord: gadolinium-enhanced MRI findings in two cases.

Gd-enhanced MR images of two patients with clinically and histopathologically diagnosed chronic progressive radiation myelitis (CPRM) were observed chronologically. One of them had had nasopharyngeal cancer and received radiotherapy at a dose of 100 Gy to the C1-2 level of the spinal cord. She developed CPRM 25 months after the termination of radiotherapy. The other had had malignant lymphoma originating from the tonsil and received chemoradiotherapy. The dose delivered to her cervical spinal cord was 40 Gy, and she developed CPRM 30 months later. Gd-enhanced MRI in the early phase revealed a small crescent-shaped nidus with or without a very small central nonenhanced area in both cases. Enhancement was not great. At that time, patients noticed only the inability to perceive pain and temperature or paresthsia in the opposite side. In a few months, MRI revealed a much more strongly enhanced and larger nidus with enlargement of a central nonenhanced area accompanied by long segmental cord enlargement. The patients' neurological symptoms had also progressed, with hemiparesis developing, for example.

Adult↗

Pathological features and pyrimidine nucleotide synthesis in human gastric carcinomas.

5-Fluorouracil, a potent anticancer drug, is clinically known to be more effective on a poorly differentiated gastric carcinoma than on a well-differentiated type. We investigated activities of thymidylate synthetase (TS) and thymidine kinase (TK) involved in de novo and salvage pathways, respectively, for pyrimidine nucleotide synthesis and histological features in 57 human gastric carcinomas. The average activities of TS in 28 poorly differentiated carcinomas and TK in 29 well-differentiated type were significantly increased to 128 and 166%, respectively, of those in normal gastric mucosa. The TK/TS ratio in the well-differentiated type was 1.7-fold higher than that in the poorly-differentiated type. Therefore, the de novo pathway for pyrimidine nucleotide synthesis is so predominant in a poorly differentiated carcinoma, but not in a well-differentiated type, that the potent TS inhibitor 5-FU or its derivatives are suggested to suppress the growth of the poorly-differentiated gastric carcinoma.

Adenocarcinoma↗

Relative activities of thymidylate synthetase and thymidine kinase in human mammary tumours.

Thymidylate synthetase (TS) and thymidine kinase (TK) are known to catalyse the methylation of dUMP for the de novo synthesis of dTMP and the phosphorylation of thymidine for the salvage synthesis of dTMP in the pyrimidine pathway, respectively. High activities of TS and TK have been observed in rapidly proliferating tissues. In the present study, both enzyme activities were measured in 8 specimens of normal mammary tissues, 12 fibroadenomas and 10 adenocarcinomas in the human breast. The average activities of TS in fibroadenomas and adenocarcinomas were approximately 5- and 7-fold that in normal mammary tissues, respectively. The average activities of TK in fibroadenomas and adenocarcinomas were 4- and 14-fold that in normal mammary tissues, respectively. Thus, DNA synthesis in benign and malignant mammary tumors may be relatively predominant in de novo and salvage pathways, respectively.

Adenocarcinoma↗

Effects of luteinizing hormone-releasing hormone analogue on DNA synthesis in rat prostate and uterus.

Buserelin, a potent LH-RH agonist, has been used for the treatment of hormonal disorders such as precocious puberty, endometriosis, cystic mastitis and prostatic carcinoma. Prolonged treatment with buserelin has been known to induce a refractory phase of pituitary desensitization. In the present study, we found that two-week treatment with buserelin strongly suppressed the activities of thymidylate synthetase and thymidine kinase, and markedly reduced the appearance of BrdU-immunoreactive (S-phase) cells in both prostate glands and uteri in male and female adult rats, respectively.

Animals↗

Effects of beta-carotene-rich algae Dunaliella bardawil on the dynamic changes of normal and neoplastic mammary cells and general metabolism in mice.

As a possible step to estimate the mechanism of the inhibitory role of Dunaliella bardawil (Db) in the initial progression of spontaneous mammary tumours of SHN virgin mice, the DNA synthesizing enzyme activities and the in vivo 31P-NMR spectroscopy of normal and neoplastic mammary cells were examined in mice fed Db. The blood levels of glucose and free fatty acids and 1H-NMR spectroscopy of serum or urine were also studied in these animals to check the general metabolic background. Beginning at 4 months of age, the experimental and the control mice were given a vitamin A deficient AIN-76TM diet supplemented with Db (the concentration of beta-carotene was 5.1 x 10(-5)%) and AIN-76TM diet containing retinyl palmitate (2.2 x 10(-4)%), respectively, until 3 weeks after mammary tumour appearance (tumourous) or 9 months of age (non-tumourous). An increasing rate of thymidine kinase activity in mammary tumour was decreased by Db, while the thymidylate synthetase activity was affected little by the treatment. Lipid synthesis was accelerated by Db in normal mammary cells; however, no difference was observed between the experimental and the control groups in energy and lipid metabolism of mammary tumour cells. The growth of preneoplastic mammary hyperplastic alveolar nodules was also enhanced by Db. Db prevented an increase of blood levels of glucose and free fatty acids and a decrease of cholin plus phosphorylcholin level after tumour appearance. Liver weights of mice given Db were greater than those of the control in both the tumourous and non-tumourous groups. Db had little effect on the urinary component levels before and after the appearance of mammary tumours. These results indicate that Db promotes the growth of normal mammary gland cells, but inhibits that of neoplastic cells, and that the inhibitory effect of Db on mammary tumour progression is due to its normalizing both the organ specific and the general metabolism.

Animals↗

Suppression by coffee cherry of the growth of spontaneous mammary tumours in SHN mice.

We previously found that coffee cherry (CC), residue after removal of coffee beans, significantly suppressed the development of spontaneous mammary tumours of mice. In this paper, the effects of CC on the growth of the palpable size of this type of tumour was examined. Free access as drinking water of 0.5% solution of the hot water extract of CC for 10 days resulted in a marked inhibition of the tumour growth: The percent changes of tumour sizes were 53.8 +/- 11.7% and 13.8 +/- 10.9% in the control and the experimental groups, respectively. Associated with this, thymidylate synthetase activity in the mammary tumours was significantly lower in the experimental group than in the control. Normal and preneoplastic mammary gland growth, body weight change and weights and structures of endocrine organs were only slightly affected by the treatment. The findings indicate that CC is promising as an antitumour agent.

Adrenal Glands↗

Effects of estrone with or without medroxyprogesterone acetate on the femur in aged rats.

In an attempt to define the efficacy of hormone replacement therapy in postmenopausal osteoporosis, we investigated the effects of estrone with or without medroxyprogesterone acetate on the bone mineral density of the femur of aged rats, of which plasma levels of luteinizing hormone (LH), follicle stimulating hormone (FSH) and estradiol were markedly reduced in comparison with those of younger rats. Although additional sex hormones had little effect on the plasma levels of gonadotropins, chronic administration of estrone significantly enhanced the bone mineral density of femur in aged animals.

Aging↗

Effects of a new clerodane diterpenoid isolated from propolis on chemically induced skin tumors in mice.

Propolis is a resinous material gathered by honey bees from the buds and bark of certain trees and plants, and used inside their hives. Characteristic components of propolis are many kinds of flavonoid aglycones. The methanol extract of a Brazilian propolis was fractionated by HPLC, and a tumoricidal substance was isolated and characterized as a new clerodane diterpenoid (PMS-1) with a molecular formula of C20H32O3 (MW: 320). We investigated the effects of PMS-1 on skin tumorigenesis and the development of skin tumors induced by 7,12-dimethylbenz(a)anthracene application on mouse back skin. It was tentatively concluded that PMS-1 reduced the incidence of skin tumors by inhibition of DNA synthesis in a de novo pathway, and suppressed the growth of the tumors by decreasing DNA synthesis in a salvage pathway.

9,10-Dimethyl-1,2-benzanthracene↗